The treatment includes airport-hospital-airport transfers and up to two night stay at Holiday Inn Hotel, located within our facilities.
Refer to our International patients section
International long distance:
Call (52 55) 5171 6440.
Or visit our Contact section
and we will call you.
El tratamiento más innovador para terminar con los síntomas de los miomas uterinos en sólo 4 horas y sin cirugía invasiva.
¡Reincorpórese a su vida normal en 24 horas!
It is a non-invasive procedure for the treatment of uterine myomas in external patients, without ionizing radiation, practically without collateral effects, and fast recovery (24 to 36 hours, in home). The treatment is realized with focused ultrasound guided by images of magnetic resonance (MRgFUS) in real time.
It was approved for its use by the European Economic Community in 2002 and by the Federal Drugs Administration (FDA) of the United States in 2004. In 2008 was recognized by the Worldwide Economic Forum as a Technological Pioneer on the health technology field.
Only two places exist in Latin America that can provide this technology; Brazil and Mexico. In Mexico is offered through Médica's Sur Magnetic Resonance Image Unit.
It is a procedure that combines two technologies: a high intensity ultrasound, that can removes the myoma tissue by heat and the magnetic resonance used for millimetrically determine the area to deal with and to live monitor the procedure of extirpation in the measurement in which it is developed.
The ultrasound
The ultrasound produces energy waves that pass through the soft skin, muscle, fat and other tissues. When it is used with diagnostic purposes, the intensity of the ultrasoundgraphics waves are very low, so this is why they do not cause any effect in the tissues or the cells.
When the high intensity waves are focused over a small size and specific objective, the temperature of the abnormal tissue rises to the point to produce its cellular death, obtaining a therapeutic effect.
A transducer (turns the electrical energy into ultrasonic energy) emits the waves through its conical shape. These high intensity waves penetrate into the body in a diffuse way until focusing in a specific zone of the myoma. When the waves concentrate at the same point, the tissue undergoes to a protein denaturation causing cellular death or coagulative necrosis.
To each one of these waves firings it is called ?sonications?. Each sonication time is about 20 seconds, and its required several of them to finish the myomas in a procedure that lasts 2 to 4 hours, depending myoma's amount and size.
The magnetic resonance
At the beginning of the treatment the magnetic resonance provides high anatomical precision images in three dimensions, that shows the tumor and the adjacent organs. These images are used to establish exactly the position of the patient and plan the treatment.
From this point the equipment of magnetic resonance is giving a live pursuit to which it happens during the treatment: as they are realized the sonications the equipment reports the changes of temperature in weaves, of such luck that the gynecologist can be directing the ultrasonic waves until covering the myomas.
The result is a considerable diminution in the size and consistency of the myomas, besides the loss of its biological activity. The patient experiences an immediate improvement of the symptoms, and in the later months, as the body is absorbing the myoma dead cells, this one continuous diminishing its size until arriving at a fraction of its original dimension, and so the symptoms that it caused are gone. Thanks to the treatment, the sonicated myomas lost their biological life and they cannot grow again. New miomas could appear with time just like in the myomectomy or in the selective embolisation of the uterine artery.
After 6 months the 70,6 percent of the women submissived to the ablation procedure has reported very significant improvements related to the uterine symptoms of myiomas; plus their uterus has not been removed. Another important information is that after the first month of the treatment, these patients lost only 1 day or maximum 2 days of work, compared with an average of 18 days of the group of patients who had a myomectomy or histerectomy.
In a study published in April of 2008 by the International Journal of Obstetrics and Gynaecology (BJOG), the relation cost/benefits from short to and medium term of the main methods to treat miomas were compared (ultrasound guided by ExAblate magnetic resonance, hysterectomy, myomectomy and selective embolisation of the uterine artery). The result is that in economic terms a difference of 10% is in favor of ExAblate and in quality terms for the life of the patient exists a level of greater satisfaction.
Immediately possible risks:
Possible risks in a nongreater term of 14 days:
Less habitual potential risks:
It is not adapted for all the patients. Excluded to:
Taking care of the oath that we make all the doctors to exert our profession, here in Médica Sur Hospital we worked in favor of the interests of the patient, always with base in a strict code of ethics. By such reason we recommended what we thought and what is better for her and it does not for our business.
We will only accept as patients those women who, by its characteristics and circumstances, are those that will benefit more from each procedure, without concerning mercantile calculations or morals benefits for Médica Sur or its doctors.
Doctors who refer us patients for explore the possibility of treat them with ExAblate can be sure that we will recommend it only if we have scientific and indubitable evidence that is the most profitable therapeutic method for them.